Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bourges

Cedric Bourges, Plerin FR

Patent application numberDescriptionPublished
20100028464USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY - Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight.02-04-2010

Cédric Bourges, Plerin FR

Patent application numberDescriptionPublished
20110236481USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY - Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight.09-29-2011

Partick Bourges, Lyon FR

Patent application numberDescriptionPublished
20090188834Doped alumino-silicate catalyst and improved process for treatment of hydrocarbon feeds - The present invention concerns doped catalysts on an alumino-silicate support with an adapted macropore content and hydrocracking/hydroconversion and hydrotreatment processes employing them. The catalyst comprises at least one hydrodehydrogenating element selected from the group formed by elements from group VIB and group VIII of the periodic table, a controlled quantity of phosphorus (optionally in combination with boron and/or silicon) as a doping element, and a non-zeolitic support based on alumina-silica containing a quantity of more than 5% by weight and 95% by weight or less of silica (SiO07-30-2009

Patrick Bourges, Lyon FR

Patent application numberDescriptionPublished
20090118556ZEOLITIC CATALYST WITH A CONTROLLED DOPING ELEMENT CONTENT, AND IMPROVED PROCESS FOR PROCESSING HYDROCARBON FEEDS - The present invention concerns doped catalysts on a mixed zeolite/alumino-silicate support with a low macropore content, and hydrocracking/hydroconversion and hydrotreatment processes employing them. The catalyst comprises at least one hydrodehydrogenating element selected from the group formed by elements from group VIB and group VIII of the periodic table and a doping element in a controlled quantity selected from phosphorus, boron and silicon, and a support based on zeolite Y defined by a lattice parameter a of the unit cell in the range 24.40×1005-07-2009
20100140138CATALYST BASED ON A MATERIAL WITH A HIERARCHICAL POROSITY COMPRISING SILICON, AND A PROCESS FOR HYDROCRACKING/HYDROCONVERSION AND HYDROTREATMENT OF HYDROCARBON FEEDS - The invention describes a catalyst comprising at least one material with a hierarchical porosity comprising silicon and at least one hydrodehydrogenating element from group VIB and/or group VIII of the periodic table of the elements. Said material with a hierarchical porosity comprising silicon is constituted by at least two elementary spherical particles, each of said spherical particles comprising zeolitic nanocrystals having a pore size in the range 0.2 to 2 nm and a matrix based on silicon oxide, which is mesostructured, having a pore size in the range 1.5 to 30 nm and having amorphous walls with a thickness in the range 1 to 30 nm, said elementary spherical particles having a maximum diameter of 100 μm. The matrix based on silicon oxide may contain aluminium. The catalyst also optionally comprises at least one doping element in a controlled quantity selected from phosphorus, boron and silicon, optionally at least one element from group VB of the periodic table of the elements, and optionally an element from group VIIA. The invention also concerns hydrocracking/hydroconversion and hydrotreatment processes employing said catalyst.06-10-2010

Patent applications by Patrick Bourges, Lyon FR

Xavier Bourges, Vay FR

Patent application numberDescriptionPublished
20100034751DEHYDRATED GRANULAR COMPOSITION AND BIOMEDICAL APPLICATIONS THEREOF - The invention relates to a granular composition for a biomaterial, that comprises from 0.1 to 5 wt % of at least one polymer derived from cellulose, 75 to 99.9 wt % of a mineral phase containing hydroxyapatite and/or β tricalcic phosphate, and 0 to 10 wt % of water, preferably 0 to 7 wt % of water, more preferably 0 to 5 wt % of water, and even more preferably approximately 5 wt % of water.02-11-2010
20110189100BONE SUBSTITUTE CONTAINING A CONTRAST AGENT, METHOD FOR PREPARING SAME AND USES THEREOF - The invention relates to a composition for biomaterials, characterised in that it comprises a calcium phosphate, in which the molar ratio Ca/P is 1 to 2, sintered with a medical imaging contrast agent uniformly distributed in the composition mass. The invention also relates to a method for preparing the same and to the medical uses thereof.08-04-2011

Xavier Bourges, Mogneneins FR

Patent application numberDescriptionPublished
20100010632SAND-BLASTING METHOD USING BIOCOMPATIBLE POLYMERS - The invention relates to a method for modifying the surface state of an implant made of polyaryletheretherketone, and for favouring the osteoconduction and osteointegration thereof in bone surgery, that comprises sand-blasting said implant with abrasive particles of calcium phosphate.01-14-2010
20100021544HYDROGEL AND BIOMEDICAL APPLICATIONS THEREOF - The invention relates to a method for preparing a cross-linked sterile and homogeneous hydrogel for injection, characterized in that it comprises the following steps: (a) preparing an aqueous solution containing a polymer derived from cellulose and at least one water-soluble polymer, the total polymer content ranging from 0.5 and 5 wt %, preferably from 1 to 4 wt % and more preferably from 1.5 to 3 wt %; (b) optionally adding sold particles; (c) pouring the resulting liquid mixture with the optional solid particles into a vessel and closing dais vessel using a water-tight and gas-tight system; and (d) exposing said vessel containing the liquid and the optional solid particles to a radiation dose of between 5 and 50 kGy, preferably between 20 and 30 kGy, and more preferably of about 25 kGy. The invention also relates to a hydrogel obtained according to the above method and to the use thereof in medical applications.01-28-2010